Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia

DSpace Repository

Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia

Author: Pfeifer, H.; Lange, T.; Wystub, S.; Wassmann, B.; Maier, J.; Binckebanck, A.; Giagounidis, A.; Stelljes, M.; Schmalzing, M.; Duehrsen, U.; Wunderle, L.; Serve, H.; Brueck, P.; Schmidt, A.; Hoelzer, D.; Ottmann, O. G.
Tübinger Autor(en):
Schmalzing, Marc
Published in: Leukemia (2012), Bd. 26, H. 7, S. 1475-1481
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/leu.2012.5
ISSN: 0887-6924
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)